The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

• Status: Not yet recruiting
• Trial end date: 2021-03-31

Summary

The aim of the study is to

1. To determine whether treatment with Erythropoiesis-stimulating agents (in the form of Aranesp®) affects platelet function, and how.

2. To determine whether salicylate treatment changes the effect of EPO (erythropoietin) on platelet function.

• Phase: N/A

Details

• Lead Sponsor: Zealand University Hospital
• Treatments: Aspirin; Salicylates